Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1985 Jun;38(6):653–658. doi: 10.1136/jcp.38.6.653

Hepatic copper distribution in primary biliary cirrhosis shown by the scanning proton microprobe.

D J Vaux, F Watt, G W Grime, J Takacs
PMCID: PMC499263  PMID: 2989341

Abstract

A number of conditions are associated with abnormalities of trace metal handling by the liver. We report the application of the Oxford scanning proton microprobe to the analysis of hepatic copper in one such condition, primary biliary cirrhosis. The scanning proton microprobe analyses conventional tissue sections (5-10 micron thickness) and produces simultaneous elemental distribution maps of biologically relevant elements with a spatial resolution of 1 micron and a detection limit better than 1 ppm. We have confirmed the localisation of excess copper to periportal areas and suggest that such accumulation is confined to a proportion of periportal hepatocytes. We have also shown a close spatial correlation between regions of copper accumulation and areas of high sulphur concentration. The copper to sulphur ratio in these areas is consistent with their identity as aggregates of copper loaded metallothionein, and the scanning proton microprobe was further able to show that the aggregates contain less than 30 ppm zinc.

Full text

PDF
653

Images in this article

654Image
on p.654
657Image
on p.657

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Briggs R. W., Armitage I. M. Evidence for site-selective metal binding in calf liver metallothionein. J Biol Chem. 1982 Feb 10;257(3):1259–1262. [PubMed] [Google Scholar]
  2. Bühler R. H., Kägi J. H. Human hepatic metallothioneins. FEBS Lett. 1974 Feb 15;39(2):229–234. doi: 10.1016/0014-5793(74)80057-8. [DOI] [PubMed] [Google Scholar]
  3. Epstein O., Arborgh B., Sagiv M., Wroblewski R., Scheuer P. J., Sherlock S. Is copper hepatotoxic in primary biliary cirrhosis? J Clin Pathol. 1981 Oct;34(10):1071–1075. doi: 10.1136/jcp.34.10.1071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fleming C. R., Dickson E. R., Baggenstoss A. H., McCall J. T. Copper and primary biliary cirrhosis. Gastroenterology. 1974 Dec;67(6):1182–1187. [PubMed] [Google Scholar]
  5. Goldfischer S., Sternlieb I. Changes in the distribution of hepatic copper in relation to the progression of Wilson's disease (hepatolenticular degeneration). Am J Pathol. 1968 Dec;53(6):883–901. [PMC free article] [PubMed] [Google Scholar]
  6. Kägi J., Coombs T. L., Overnell J., Webb M. Synthesis and function of metallothioneins. Nature. 1981 Aug 6;292(5823):495–496. doi: 10.1038/292495a0. [DOI] [PubMed] [Google Scholar]
  7. OSWALD N. C. ACUTE TUBERCULOSIS AND GRANULOCYTIC DISORDERS. Br Med J. 1963 Dec 14;2(5371):1489–1496. doi: 10.1136/bmj.2.5371.1489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Riordan J. R., Richards V. Human fetal liver contains both zinc- and copper-rich forms of metallothionein. J Biol Chem. 1980 Jun 10;255(11):5380–5383. [PubMed] [Google Scholar]
  9. Rydén L., Deutsch H. F. Preparation and properties of the major copper-binding component in human fetal liver. Its identification as metallothionein. J Biol Chem. 1978 Jan 25;253(2):519–524. [PubMed] [Google Scholar]
  10. Smallwood R. A., Williams H. A., Rosenoer V. M., Sherlock S. Liver-copper levels in liver disease: studies using neutron activation analysis. Lancet. 1968 Dec 21;2(7582):1310–1313. doi: 10.1016/s0140-6736(68)91814-x. [DOI] [PubMed] [Google Scholar]
  11. UZMAN L. L. Histochemical localization of copper with rubeanic acid. Lab Invest. 1956 May-Jun;5(3):299–305. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES